IN168119B - - Google Patents

Info

Publication number
IN168119B
IN168119B IN837/CAL/87A IN837CA1987A IN168119B IN 168119 B IN168119 B IN 168119B IN 837CA1987 A IN837CA1987 A IN 837CA1987A IN 168119 B IN168119 B IN 168119B
Authority
IN
India
Prior art keywords
ifosfamide
weight
hexitol
optionally
parts
Prior art date
Application number
IN837/CAL/87A
Inventor
Dieter Sauerbier
Uwe Peter Dammann
Otto Isaac
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of IN168119B publication Critical patent/IN168119B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Control Of El Displays (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Indole Compounds (AREA)
  • Amplifiers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1. A lyophilized preparation consisting of ifosfamide and 0.1 to 17 parts by weight hexitol per part by weight ifosfamide and, optionally, other standard pharmaceutical auxiliaries.
IN837/CAL/87A 1986-10-31 1987-10-26 IN168119B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31

Publications (1)

Publication Number Publication Date
IN168119B true IN168119B (en) 1991-02-09

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
IN837/CAL/87A IN168119B (en) 1986-10-31 1987-10-26

Country Status (25)

Country Link
EP (1) EP0265812B1 (en)
JP (1) JPS63159319A (en)
KR (1) KR900003491B1 (en)
AT (1) ATE55250T1 (en)
AU (1) AU598602B2 (en)
CA (1) CA1314231C (en)
DD (1) DD262582A5 (en)
DE (1) DE3764235D1 (en)
DK (1) DK169308B1 (en)
EG (1) EG18333A (en)
ES (1) ES2017982B3 (en)
FI (1) FI87140C (en)
GE (1) GEP19971025B (en)
GR (1) GR3000708T3 (en)
HU (1) HU197987B (en)
IL (1) IL84312A (en)
IN (1) IN168119B (en)
LV (1) LV10051B (en)
MX (1) MX8958A (en)
NO (1) NO873860L (en)
PT (1) PT86032B (en)
RU (1) RU1836079C (en)
UA (1) UA11075A (en)
YU (1) YU197387A (en)
ZA (1) ZA878183B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0334083B1 (en) * 1988-03-19 1991-07-24 ASTA Pharma Aktiengesellschaft Ifosfamide-mesna-lyophilized composition and process to prepare it
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (en) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamide lyophilizate preparations
ES2253877T3 (en) * 1998-03-03 2006-06-01 SHIONOGI & CO., LTD. PHARMACEUTICAL COMPOSITIONS CONTAINING THE PHOSPHOLIPASE INHIBITOR ((3- (2-AMINO-1,2-DIOXOETIL) -2-ETIL-1- (PHENYLMETIL) -1H-INDOL-4-IL) OXI) SODIUM ACETATE.
US20050272698A1 (en) * 2002-09-05 2005-12-08 Daftary Gautam V Liquid stable composition of oxazaphosphorine with mesna
KR101066181B1 (en) * 2002-12-02 2011-09-20 바라트 쎄럼스 앤드 백신스 리미티드 Ifosfamide Compositions for Parenteral Administration and a Process for Their Preparation
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
PL2071917T3 (en) * 2006-09-29 2013-04-30 Infa Sa Packaging system for pharmaceutical compositions and kit for intravenous administration
WO2016087001A1 (en) * 2014-12-04 2016-06-09 Huawei Technologies Co., Ltd. Load allocation in a data communication network

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (en) * 1977-05-09 1978-11-16 Walton J Smith Anhydrous compsn. prodn. by freeze drying hydrated, hydrolysable prod. - esp. aspirin or aspirin salt solns.
EP0083439B1 (en) * 1981-12-31 1989-07-26 ASTA Pharma AG 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
PT86032A (en) 1987-11-01
EP0265812B1 (en) 1990-08-08
LV10051B (en) 1995-06-20
NO873860L (en) 1988-05-02
NO873860D0 (en) 1987-09-15
FI874727A (en) 1988-05-01
DK569687D0 (en) 1987-10-30
LV10051A (en) 1994-05-10
EP0265812A1 (en) 1988-05-04
FI87140C (en) 1992-12-10
AU598602B2 (en) 1990-06-28
ATE55250T1 (en) 1990-08-15
EG18333A (en) 1993-12-30
YU197387A (en) 1988-12-31
GR3000708T3 (en) 1991-10-10
KR880004814A (en) 1988-06-27
JPH0543684B2 (en) 1993-07-02
HUT44932A (en) 1988-05-30
AU8052987A (en) 1988-05-05
DE3764235D1 (en) 1990-09-13
ZA878183B (en) 1988-05-02
UA11075A (en) 1996-12-25
IL84312A (en) 1991-11-21
DD262582A5 (en) 1988-12-07
CA1314231C (en) 1993-03-09
ES2017982B3 (en) 1991-03-16
DK569687A (en) 1988-05-01
GEP19971025B (en) 1997-04-06
PT86032B (en) 1990-08-31
DK169308B1 (en) 1994-10-10
FI874727A0 (en) 1987-10-27
MX8958A (en) 1993-12-01
IL84312A0 (en) 1988-03-31
JPS63159319A (en) 1988-07-02
FI87140B (en) 1992-08-31
KR900003491B1 (en) 1990-05-21
HU197987B (en) 1989-07-28
RU1836079C (en) 1993-08-23

Similar Documents

Publication Publication Date Title
EP0196524A3 (en) Phenoxyalkylaminopyrimidine derivatives, their preparation and insecticidal and acaricidal compositions containing them
ZA894728B (en) A new pharmaceutical formulation as well as a process for its preparation
GR3002377T3 (en) Ifosfamide-mesna-lyophilized composition and process to prepare it
GR3007251T3 (en)
HUT44438A (en) Composition comprising l-dopa
IL95946A0 (en) Preparation of tetrabromo-4,4'-alkylidenediphenols
IN168119B (en)
EG18437A (en) Insecticidal n-substituted-n'-substituted-n,n'-diacylhydrazines
ZA886107B (en) Antiviral preparation
IL87134A0 (en) Preparation of 1,2,4-triazol-3-ones
GR3001481T3 (en) Preparation of trichlorophenol
KR900700484A (en) Aminopropanol derivative of 1,4: 3,6-dianhydro hexitol salate, its preparation and use as a medicament
AU1517788A (en) Analogs of (1,7-DI-Alanine, des-19-leucine)
IL89631A0 (en) Preparation of 2,6-dioxopiperidine derivatives
IL88849A0 (en) Preparation of 1,5-benzo-thiazepine derivatives
IL87173A (en) 4-heterocyclyl thio-phenyl-thiourea,isothiourea and/or carbodiimide derivatives,their preparation and insecticidal and acaricidal compositions containing them
IL83606A0 (en) Derivatives of 2,2-dimethyl-cyclopropanecarboxylic acid,their preparation and their use as insecticides and acaricides
IL82668A0 (en) Preparation of 2,2-bis-chloro-methyl-alkanecarboxylic acid chlorides
IL85856A0 (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2,its acid addition salts and pharmaceutical compositions containing them
IE861999L (en) Preparation of 5,6-dialkoxyanthranilic acids
IL82031A0 (en) Substituted benzeneacrylic acids,their preparation and pesticidal compositions containing them
ZA861906B (en) Phenoxyalkylaminopyrimidine derivatives,their preparation and insecticidal and acaricidal composition containing them